These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 1665087

  • 1. [New perspectives in the search for a vaccine against the Epstein-Barr virus].
    Cour Boveda MI, Yagüe García V.
    An Med Interna; 1991 Nov; 8(11):527-8. PubMed ID: 1665087
    [No Abstract] [Full Text] [Related]

  • 2. Candidate vaccines for Epstein-Barr virus.
    Moss DJ, Suhrbier A, Elliott SL.
    BMJ; 1998 Aug 15; 317(7156):423-4. PubMed ID: 9703518
    [No Abstract] [Full Text] [Related]

  • 3. Vaccine control of malignancies induced by lymphotropic herpesviruses.
    Epstein MA, North JR, Morgan AJ.
    Prog Clin Biol Res; 1983 Aug 15; 132B():61-70. PubMed ID: 6314351
    [No Abstract] [Full Text] [Related]

  • 4. Control of viral disease: the development of Epstein-Barr virus vaccines.
    Morgan AJ.
    Springer Semin Immunopathol; 1991 Aug 15; 13(2):249-62. PubMed ID: 1664989
    [No Abstract] [Full Text] [Related]

  • 5. Vaccination against herpesvirus, fiction or reality?
    Morein B, Merza M.
    Scand J Infect Dis Suppl; 1991 Aug 15; 80():110-8. PubMed ID: 1666442
    [Abstract] [Full Text] [Related]

  • 6. Liposomal subunit vaccine against Epstein-Barr virus-induced malignant lymphoma.
    Gregoriadis G.
    Nature; 1991 Aug 15; 320(6057):87-8. PubMed ID: 3005876
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epstein-barr-virus nuclear antigen.
    Vonka V, Hirsch I.
    Prog Med Virol; 1982 Aug 15; 28():145-79. PubMed ID: 6283600
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug 15; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 15. T-cell memory: lessons from Epstein-Barr virus infection in man.
    Rickinson AB, Callan MF, Annels NE.
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar 29; 355(1395):391-400. PubMed ID: 10794060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus.
    Hollier LM, Grissom H.
    Clin Perinatol; 2005 Sep 29; 32(3):671-96. PubMed ID: 16085026
    [Abstract] [Full Text] [Related]

  • 18. Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
    Epstein MA, Randle BJ, Finerty S, Kirkwood JK.
    Clin Exp Immunol; 1986 Mar 29; 63(3):485-90. PubMed ID: 3011324
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus infections.
    Middleton PJ.
    Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535
    [No Abstract] [Full Text] [Related]

  • 20. Manipulation of the immune response by Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus: consequences for tumor development.
    Ressing ME, Wiertz EJ.
    Semin Cancer Biol; 2008 Dec 05; 18(6):379-80. PubMed ID: 18992819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.